Delisted
Stopped trading. Last price we have: $58.02 on Mar 2, 2026. Fund positions aren't valued until we confirm what happened.
RAPT THERAPEUTICS INC
RAPT·75382E109·UW·Common Stock·Healthcare - Biotechnology-13D/G
RAPT (RAPT THERAPEUTICS INC) is held by 0 institutional investors as of Q1 2026.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold RAPT.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $2.6M | 0.0% | +73.83% | 0 | |
Exited | 0(-100.0%) | $5.7M | 0.0% | +109.52% | 0 | |
Exited | 0(-100.0%) | $331,384 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $424,222 | 0.0% | +117.96% | 0 | |
Exited | 0(-100.0%) | $21.7M | 0.0% | +54.55% | 0 | |
Exited | 0(-100.0%) | $64,223 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | +64.90% | 0 | |
Exited | 0(-100.0%) | $2M | 0.0% | +81.37% | 0 | |
Exited | 0(-100.0%) | $8.1M | 0.0% | -16.40% | 0 | |
Exited | 0(-100.0%) | $616,265 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $832,254 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $2.2M | 0.0% | +84.90% | 0 | |
Exited | 0(-100.0%) | $346,084 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1,000 | 0.0% | +574.73% | 0 | |
Exited | 0(-100.0%) | $14.4M | 0.0% | +77.66% | 0 | |
Exited | 0(-100.0%) | $16.5M | 0.0% | +96.01% | 0 | |
Exited | 0(-100.0%) | $55.5M | 0.0% | +285.80% | 0 | |
Exited | 0(-100.0%) | $392,892 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $9.3M | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | +73.82% | 0 |
Showing 1-20 of 50
1 / 3
RAPTRAPT THERAPEUTICS INCContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Inc416 holders · $299.1B
LLYEli Lilly & Co415 holders · $877.5B
TMOThermo Fisher Scientific Inc400 holders · $151.4B
JNJJohnson & Johnson397 holders · $414.1B
DHRDanaher Corp394 holders · $97.5B
ISRGIntuitive Surgical Inc393 holders · $111.5B
MRKMerck & Co Inc390 holders · $230.1B
ABBVAbbVie Inc385 holders · $302.9B
BSXBoston Scientific Corp385 holders · $51.8B
ABTAbbott Laboratories382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer